[The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
D000014:Abnormalities, Drug-Induced; D000284:Administration, Oral; D000818:Animals; D001381:Azepines / Q000633:toxicity*; D001786:Blood Glucose; D001835:Body Weight; D002415:Cats; D003864:Depression, Chemical; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005260:Female; D005298:Fertility / Q000187:drug effects; D005951:Glucose Tolerance Test; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000633:toxicity*; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced; D010080:Oxazoles / Q000633:toxicity*; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012640:Seizures / Q000139:chemically induced; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000633:toxicity*; D013997:Time Factors
D001381:Azepines; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D010080:Oxazoles; D013453:Sulfonylurea Compounds
Zur Toxikologie von Glisoxepid, einem neuen oralen Antidiabetikum. Ergebnisse der Tierversuche